Interpace Biosciences, Inc.

Interpace Biosciences, Inc. - ROEverified

IDXG

Price:

$1.667

Market Cap:

$46.18M

Interpace Biosciences, Inc. is a U.S.-based company specializing in advanced molecular diagnostic tests, bioinformatics, and pathology services, primarily focused on assessing cancer risk. Among its key offerings is PancraGEN, a comprehensive genomic test for pancreatic cysts and solid lesions within the pancreaticobiliary system. This test, powered by the proprietary PathFinderTG platform, assists medical professionals in more accurately determining the risk of pancreaticobiliary cancers. It also offers PanDNA, a molecular-only variant of PancraGEN, which delivers insights into a select number of diagnostic markers. For thyroid health, the company provides ThyGeNEXT, an oncogenic mutation p...[Read more]

Industry

Medical - Diagnostics & Research

IPO Date

1998-05-20

Stock Exchange

OTC

Ticker

IDXG

The ROE as of June 2026 (TTM) for Interpace Biosciences, Inc. (IDXG) is 215.31%

According to Interpace Biosciences, Inc.’s latest financial reports and current stock price. The company's current ROE is 215.31%. This represents a change of -679.95% compared to the average of -37.13% of the last 4 quarters.

Interpace Biosciences, Inc. (IDXG) Historical ROE (quarterly & annually)

How has IDXG ROE performed in the past?

The mean historical ROE of Interpace Biosciences, Inc. over the last ten years is -46.32%. The current 215.31% ROE has changed -564.83% with respect to the historical average. Over the past ten years (40 quarters), IDXG's ROE was at its highest in in the September 2016 quarter at 506.63%. The ROE was at its lowest in in the June 2020 quarter at -324.63%.

Quarterly (TTM)
Annual

Average

-46.32%

Median

-17.93%

Minimum

-302.30%

Maximum

109.89%

Interpace Biosciences, Inc. (IDXG) ROE by Quarter and Year

Discovering the peaks and valleys of Interpace Biosciences, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 5.61%

Maximum Annual ROE = 109.89%

Minimum Annual Increase = -156.98%

Minimum Annual ROE = -302.30%

Quarterly (TTM)
Annual
YearROEChange
2025109.89%-136.35%
2024-302.30%5.61%
2023-5.30%-156.98%
20229.30%-73.25%
202134.76%-61.41%
202090.09%-144.05%
2019-204.51%452.63%
2018-37.01%21.08%
2017-30.56%-76.04%
2016-127.58%46.47%

Interpace Biosciences, Inc. (IDXG) Average ROE

How has IDXG ROE performed in the past?

The current ROE of Interpace Biosciences, Inc. (IDXG) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-65.90%

5-year avg

-30.73%

10-year avg

-46.32%

Interpace Biosciences, Inc. (IDXG) ROE vs. Peers

How is IDXG’s ROE compared to its peers?

Interpace Biosciences, Inc.’s ROE is less than Rennova Health, Inc. (23.45%), less than Telo Genomics Corp. (902.36%), greater than iMD Companies, Inc. (-21.61%), greater than Avricore Health Inc. (-227.06%), less than Reflect Scientific, Inc. (10.06%), less than Stella Diagnostics Inc. (17.12%), greater than REMSleep Holdings, Inc. (-4042468745.17%), greater than LFTD Partners Inc. (-54.89%), greater than Captiva Verde Wellness Corp. (-81.17%), less than Revive Therapeutics Ltd. (288.66%),

Build a custom stock screener for Interpace Biosciences, Inc. (IDXG) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Interpace Biosciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Interpace Biosciences, Inc. (IDXG) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Interpace Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Interpace Biosciences, Inc.'s ROE?

How is the ROE calculated for Interpace Biosciences, Inc. (IDXG)?

What is the highest ROE for Interpace Biosciences, Inc. (IDXG)?

What is the 3-year average ROE for Interpace Biosciences, Inc. (IDXG)?

What is the 5-year average ROE for Interpace Biosciences, Inc. (IDXG)?

How does the current ROE for Interpace Biosciences, Inc. (IDXG) compare to its historical average?